Cardiol Therapeutics Statistics
Share Statistics
Cardiol Therapeutics has 82.65M
shares outstanding. The number of shares has increased by 18.27%
in one year.
| Shares Outstanding | 82.65M |
| Shares Change (YoY) | 18.27% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 10.88% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,626 |
| FTD / Avg. Volume | 2.9% |
Short Selling Information
The latest short interest is 1.84M, so 2.23% of the outstanding
shares have been sold short.
| Short Interest | 1.84M |
| Short % of Shares Out | 2.23% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 13.68 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -2.58 |
| PS Ratio | 0 |
| Forward PS | 0.9 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardiol Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.52,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.52 |
| Quick Ratio | 4.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,562,682.83 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -50.38% in the
last 52 weeks. The beta is 0.76, so Cardiol Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.76 |
| 52-Week Price Change | -50.38% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 67.08 |
| Average Volume (20 Days) | 193,958 |
Income Statement
| Revenue | n/a |
| Gross Profit | -248.35K |
| Operating Income | -29.79M |
| Net Income | -28.13M |
| EBITDA | -29.59M |
| EBIT | -29.79M |
| Earnings Per Share (EPS) | -0.44 |
Full Income StatementBalance Sheet
The company has 30.58M in cash and 158.53K in
debt, giving a net cash position of 30.42M.
| Cash & Cash Equivalents | 30.58M |
| Total Debt | 158.53K |
| Net Cash | 30.42M |
| Retained Earnings | -179.25M |
| Total Assets | 31.86M |
| Working Capital | 24.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -25.06M
and capital expenditures -21.29K, giving a free cash flow of -25.08M.
| Operating Cash Flow | -25.06M |
| Capital Expenditures | -21.29K |
| Free Cash Flow | -25.08M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
